Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases

By afschroeder • June 6, 2026

Juarez Casillas JE, Nezafat M, Benitez CM, Rzechowski K, Kane N, Sjöstrand K, Anand A, Sonni I, Berenji GR, Duriseti S, Rettig MB, Nickols NG. Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases. PLoS One. 2026 Jun 5;21(6):e0349825. doi: 10.1371/journal.pone.0349825. PMID: 42247403; PMCID: PMC13240907.

Tags: Hematology/Oncology, Publications, Veterans Administration

Response to Zhang and Shi

Ji J, Cohen HJ, Sedrak MS. Response to Zhang and Shi. J Natl Cancer Inst. 2026 Oct 12:djag380. doi: 10.1093/jnci/djag380. Epub ahead of print. PMID:[...]

177Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial

Kishan AU, Wilhalme H, Felix C, Enke J, Ali FZ, Nabong R, Juarez-Casillas JE, Flores K, Ma TM, Ludwig V, Nakayama M, Ells Z, Dahlbom[...]

Author Correction: PAK4 inhibition improves PD-1 blockade immunotherapy

Abril-Rodriguez G, Torrejon DY, Liu W, Zaretsky JM, Nowicki TS, Tsoi J, Puig-Saus C, Baselga-Carretero I, Medina E, Quist MJ, Garcia AJ, Senapedis W, Baloglu[...]